Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Basel Medical (BMGL) Cash & Equivalents: 2024-2025

Historic Cash & Equivalents for Basel Medical (BMGL) over the last 2 years, with FY2025 value amounting to $2.3 million.

  • Basel Medical's Cash & Equivalents rose 6242.07% to $2.3 million in Q2 2025 from the same period last year, while for Jun 2025 it was $2.3 million, marking a year-over-year increase of 6242.07%. This contributed to the annual value of $2.3 million for FY2025, which is 6182.24% up from last year.
  • Per Basel Medical's latest filing, its Cash & Equivalents stood at $2.3 million for FY2025, which was up 6182.24% from $1.4 million recorded in FY2024.
  • In the past 5 years, Basel Medical's Cash & Equivalents ranged from a high of $2.3 million in FY2025 and a low of $1.4 million during FY2024